Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Prof/ David Nutt
Recent news which mentions Prof/ David Nutt
U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy
October 15, 2023
Tickers
AWKNF
Tags
Market News
Prof/ David Nutt
AWKNF
From
Benzinga
British Prof. David Nutt Talks About Need For Psychedelic-Assisted Therapy During Australia Visit
December 01, 2022
Tags
News
Cannabis
Psychedelic/Assisted Therapies
From
Benzinga
Clearmind Gears Up For Clinical Trial To Test Drug That Treats Alcohol Addiction
November 23, 2022
Tickers
CMND
Tags
Management
Psychedelics/Assisted Therapies
Penny Stocks
From
Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: The Legal Situation
September 19, 2022
Tags
Market News
Prof/ David Nutt
Markets
From
Benzinga
A Foundational Study On Stroke Is Ready. Here Is Why It's Important
September 12, 2022
Tickers
AGNPF
DMT
Tags
Contracts
Benzinga
Markets
From
Benzinga
Australia: An Initial $700K In Funding For Observational Trials Of Psychedelic-Assisted Therapies
August 24, 2022
Tags
Benzinga
Markets
Market News
From
Benzinga
UK: Psychiatrists Send Letter To Royal College Of Psychiatrists To Reschedule Psilocybin
July 20, 2022
Tags
Global
Conservative Drug Policy Reform Group (CDPRG)
Dr/ Adrian James
From
Benzinga
Meet PAREA, The European Partnership For Novel Psychedelic-Assisted Therapies Access & Research Is Launching This June
June 14, 2022
Tags
Global
Psychedelics
Market News
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.